soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Canadian Perspectives Whiteboard on the SELECT Trial

If a patient has several metabolic conditions, poorly controlled diabetes, or a history of bariatric surgery, a specialist can offer more nuanced medication management

Review the denial letter carefully to understand the exact reason for the denial and gather evidence to counter it

Regarding clinical studies, in a phase II 48-week randomized controlled trial, the GLP-1R agonist liraglutide induced resolution of NASH in both diabetic and nondiabetic patients, as well as improved steatosis and ballooning 17

Preparation matters too

Validation with longitudinal studies with a larger population size would further help to develop early screening tools for AD based on the same idea and is under process in our lab